How Is The Market Feeling About Regeneron Pharmaceuticals?
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NYSE:REGN) has seen a decrease in short interest, with the short percent of float dropping 4.67% since the last report. The company has 1.31 million shares sold short, which is 1.43% of available shares for trading. The current short interest is lower than the peer group average of 4.17%. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price.
November 16, 2023 | 4:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regeneron Pharmaceuticals has experienced a decline in short interest, which may suggest a more bullish sentiment among investors. However, this does not guarantee an immediate increase in stock price.
A decrease in short interest typically indicates that investors are less bearish on a stock, which could lead to a potential increase in its price. However, the impact on the stock price is not immediate and can be influenced by various other market factors.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80